PKU RES-NEW (00618) Partners with Trivitron Healthcare to Jointly Launch Trivitron Digital AI

Stock News
01/09

PKU RES-NEW (00618) announced that its Dubai-based health business unit, ResoHealth, has entered into a strategic partnership with Trivitron Healthcare to jointly launch Trivitron Digital AI. This groundbreaking digital health initiative is designed to revolutionize healthcare delivery models in India's tier 2 and 3 cities. The collaboration specifically aims to address India's urgent demand for advanced digital infrastructure. By combining the strengths of Trivitron Healthcare and ResoHealth, Trivitron Digital AI offers innovative solutions that transform hospital operations in patient care, data management, and doctor-patient interactions, while simultaneously driving improvements in healthcare system interoperability and operational efficiency. The platform seeks to bridge the digital divide by providing hospitals with integrated cloud-based solutions, thereby enhancing operational efficiency and enabling patient-centric AI-powered diagnostics and treatment. It features a comprehensive suite of tools, including: a Laboratory Information System (LIS) that optimizes sample tracking and remote report review processes; a Web-based Picture Archiving and Communication System (Web-PACS) that facilitates image data sharing via secure online access to boost clinical collaboration; and a Personal Health Record (PHR) with a mobile-first design to empower patients in managing their own health information. These interoperable solutions are developed in compliance with global standards such as HL7, FHIR, DICOM, HIPAA, GDPR, and ABHA, and require minimal additional infrastructure, making them particularly suitable for regions with lower levels of digitalization. Trivitron Digital AI will be led by Dr. G.S.K. Velu, Chairman and Managing Director of Trivitron Healthcare, and Dr. Vas Metupalle. Dr. G.S.K. Velu emphasized the critical importance of transitioning to integrated digital ecosystems in healthcare, stating, "Through the Trivitron Digital AI platform, we are laying the foundation for mid-sized hospitals and diagnostic networks to deliver high-quality, transparent healthcare regardless of their location." Dr. Vas Metupalle elaborated on the platform's core philosophy, which focuses on patient empowerment and ease of use, aiming to achieve seamless management of health information. Beyond the Indian market, Trivitron Digital AI plans to expand into Africa, the Middle East, and Southeast Asia to address similar healthcare challenges and help local medical institutions benefit from interconnected healthcare solutions. This launch represents a significant step forward in the mission to promote the global accessibility of digital healthcare. By fusing interoperable platforms with AI-powered automation, Trivitron Digital AI is set to redefine healthcare delivery models, making them more inclusive and ensuring high-quality medical care is within reach for more people.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10